clinical trial · NCT05131100
Korean Regulatory Post Marketing Surveillance for Somavert
Pfizer·—·recruiting·n = 100
AcromegalySomavert
brief summary
Non-interventional observational study, to identify safety and effectiveness of Somavert during the post-marketing period based on the Korean RMP as required by the regulations of Ministry of Food and Drug Safety (MFDS)
started
Jul 13, 2022
primary completion
Sep 15, 2026
completion
Sep 15, 2026
last updated
Jul 4, 2025
official title
Korean Post-marketing Surveillance for Somavert
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol